Suppliers
Contact Us
 GENTAUR Europe BVBAVoortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45 Fax 0032 16 50 90 45 This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it. |
GENTAUR BULGARIA
53 Iskar Str. 1191 Kokalyane, Sofia
Tel 0035924682280
Fax 0035929830072
This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.
GmbH Marienbongard 20
52062 Aachen Deutschland
Tel (+49) 0241 56 00 99 68
Fax (+49) 0241 56 00 47 88 This email address is being protected from spambots. You need JavaScript enabled to view it." style="font-family: Arial, Tahoma, Verdana, Helvetica; line-height: 15.59375px; ">
This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it." style="font-size: 12px; line-height: 1.3em;">
This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531
Fax 020 8445 9411
This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
Tel 058 710 33 44
Fax 058 710 33 48
This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.
GENTAUR Nederland BV
Kuiper 1
5521 DG Eersel Nederland
Tel 0208-080893
Fax 0497-517897
This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.
GENTAUR SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6, 24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it.
GENTAUR Spain
Tel 0911876558
This email address is being protected from spambots. You need JavaScript enabled to view it." style="">This email address is being protected from spambots. You need JavaScript enabled to view it.
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Phone/Fax:
(408) 780-0908
This email address is being protected from spambots. You need JavaScript enabled to view it.
GENPRICE Inc. invoicing/ accounting:
6017 Snell Ave, Suite 357
San Jose, CA. 96123
Serbia, 
Macedonia,
Montenegro, 
Croatia:
Tel 0035929830070
Fax 0035929830072
This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it.
GENTAUR Romania
Tel 0035929830070
Fax 0035929830072
This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it.
GENTAUR Greece
Tel 00302111768494
Fax 0032 16 50 90 45
This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it.
Other countries
Luxembourg +35220880274
Schweiz Züri +41435006251
Danmark +4569918806
Österreich +43720880899
Ceská republika Praha +420246019719
Ireland Dublin +35316526556
Norge Oslo +4721031366
Finland Helsset +358942419041
Sverige Stockholm +46852503438
Magyarország Budapest +3619980547
NATtrol CT.NG External Run Controls
PRODUCT DESCRIPTION:
NATtrol™ CT.NG External Run Controls (NATCT (434)-6MC, NATNG-6MC and NATCT.NGNEG-6MC) are formulated with purified, intact bacterial particles that have been chemically modified to render them non-infectious and refrigerator stable*. Each control pack contains 6 x 1.0 mL vials of C.trachomatis NATtrolTM, N.gonorrhoeae NATtrolTM or CT.NG Negative NATtrolTM. These controls are supplied in a purified protein matrix that mimics the composition of a true clinical specimen. *NATtrol™ Patents Pending
INTENDED USE:
- NATtrol™ CT.NG External Run Controls are full process controls designed to evaluate the performance of nucleic acid tests for determination of the presence of CT.NG DNA. NATCT(434)-6MC, NATNG-6MC and NATCT.NGNEG-6MC can also be used for quality control of clinical assays and training of laboratory personnel.
- NATCT(434)-6MC, NATNG-6MC and NATCT.NGNEG-6MC contain intact organisms and should be run in a manner identical to that used for clinical specimens.
ETIOLOGIC STATUS/BIOHAZARD TESTING:
- NATtrol™ inactivation was carried out on each control. The inactivation was verified by the absence of bacterial growth in a validated growth protocol.
- The purified protein matrix was manufactured from materials that were screened and found to be negative for HIV 1&2 Ab, HBsAg, HTLV I&II Ab, HCV Ab, HIV RNA, HBV DNA and HCV RNA using FDA cleared kits at the single donor level.
Catalog #:NATNG-6MC
Catalog #:NATCT(434)-6MC
Catalog #:NATCT.NGNEG-6MC
For more information download PDF file
NATtrol BC.GP Panel
PRODUCT DESCRIPTION:
NATtrol™ BC.GP Panel (NATBC.GP-NNS) is formulated with purified, intact bacterial particles that have been chemically modified to render them non-infectious and refrigerator stable*. NATBC.GP-NNS contains 11 x 0.75 mL vials of bacterial NATtrol™ targets listed in Table 1. These panels are supplied in a purified protein matrix that mimics the composition of a true clinical specimen. *NATtrol™ Patents Pending
INTENDED USE:
- NATtrol™ BC.GP Panel is designed to evaluate the performance of nucleic acid tests for determination of the presence of bacterial nucleic acids. NATBC.GP-NNS can also be used for verification of clinical assays, development of diagnostic tests and training of laboratory personnel.
- NATBC.GP-NNS contains intact organisms and should be run in a manner identical to that used for clinical specimens.
ETIOLOGIC STATUS/BIOHAZARD TESTING:
- NATtrol™ inactivation was carried out on the bacterial stock used to formulate panel members. The inactivation was verified by the absence of bacterial growth in a validated growth protocol.
- The purified protein matrix was manufactured from materials that were screened and found to be negative for HIV 1&2 Ab, HBsAg, HTLV I&II Ab, HCV Ab, HIV RNA, HBV DNA and HCV RNA using FDA cleared kits at the single donor level.
PRECAUTIONS:
- Although NATBC.GP-NNS contains inactivated organisms, it should be handled as if potentially infectious.
- Use Universal Precautions when handling this product.
- To avoid cross-contamination, use separate pipette tips for all reagents.
Catalog #: NATBC.GP-NNS
For more information donwload PDF file
Background Buster Peptide Blocker for Removal of background staining
A MUST FOR:
- - Mouse-On-Mouse
- - Human and Animal IHC
- - Immunofluorescence
- - in-situ Hybridization
Background Buster is highly effective for quenching background fluorescence and is easy to use:
For Fluorescence:
- Apply Background Buster for 15 minutes prior to application of the first antibody (unlabeled or fluorescence-labeled antibody).
- Rinse with PBS for 1 minute.
- Apply unlabeled antibody for indirect method or fluorescence labeled antibody for direct method and continue with usual protocol.
Background Buster can be used for IHC:
Background or non-specific staining is often observed in a variety of immunoassays, in immunohistochemistry and other immunoassay types such as immunofluorescence, ELISA and flow cytometric assays, background staining can be prevented by the use of INNOVEX Recombinant Protein Technology,Background Buster.
Background Buster is also applicable to eliminating non-specific binding in immunofluorescence, ELISA and flow cytometric assays.
ADVANCED & UNIQUE FEATURES:
• Allows staining of identical species antibodies and tissues (e.g., mouse antibody on mouse tissue, rat-on-rat, rabbit-on-rabbit, etc.).
• Short 10 minute incubation step prior to applying primary antibody or in-situ probe at room temperature
• Delivers complete eradication of general background staining
• Replaces the use of normal serum, powdered milk, casein, and other blocking agents and renders complete success
• Excellent for both frozen and paraffin sections
• Excellent for in situ application
• A must for animal tissue staining
25OH Vitamin D Total, ELISA, 96 tests
The Gentaur 25OH Vitamin D Total ELISA is a solid phase Enzyme Linked Immunosorbent Assay performed on microtiterplates. During a first 2 hours incubation step, at room temperature, total 25OH Vitamin D (D2 and D3) present in calibrators, controls and samples is dissociated from binding serum proteins to fix on binding sites of a specific monoclonal antibody. After 1 washing step, a fixed amount of 25OH Vitamin D-labelled with biotin in presence of horseradish peroxidise (HRP), compete with unlabelled 25OH Vitamin D2 and 25OH Vitamin D3 present on the binding sites of the specific monoclonal antibody. After a 30 minutes incubation at room temperature, the microtiterplate is washed to stop the competition reaction. The Chromogenic solution (TMB) is added and incubated for 15 minutes. The reaction is stopped with the addition of Stop Solution and the microtiterplate is then read at the appropriate wavelength. The amount of substrate turnover is determined colourimetrically by measuring the absorbance, which is inversely proportional to the total 25OH Vitamin D (D2 and D3) concentration. A calibration curve is plotted and the total 25OH Vitamin D (D2 and D3) concentrations of the samples are determined by dose interpolation from the calibration curve.
Price: 250 €
Technical spec.:
| Catalog # | KAP1971 |
| Format | ELISA |
| Label | HRP |
| Size | 96 tests |
| Sample Type | Serum |
| Sample Volume | 50 µL |
| Controls | 2 levels |
| Range | 0-180 ng/mL |
| Sensitivity | 1,4 ng/mL |
| Incubation | 120min./30 min./15 min |
| Shelf Life (weeks) | 32 |
Enterococcus faecium VRE; vanA, titered (1 mL)
PRODUCT DESCRIPTION: Each frozen aliquot contains 1 mL of a pure, titered culture of Enterococcus faecium. The identification of this organism was confirmed by 16S sequencing. The purity of the culture was monitored by Gram staining and by additional culturing. The titer was performed on one aliquot after freezing. The freezing medium contains 15% glycerol as a cryoprotectant. Please see the Certificate of Analysis for the specific freezing medium used.
INTENDED USE: Live, titered microorganisms can be used to determine a limit of detection (LOD), in diagnostic assay development or crossreactivity studies. When used as a control for nucleic acid tests, the same protocols as those used to amplify clinical specimens should be employed.
BIOSAFETY: Enterococcus faecium is a biosafety level 2 microorganism and must be used within Biological Safety Level 2 facility or cabinet. Please consult your institution’s regulations regarding the use of this organism.
PRECAUTIONS:
- Use Universal Precautions, this organism is potentially biohazardous.
- Repetitive freezing and thawing is not recommended (aliquot material if necessary). Titer will be altered by a single freeze-thaw.
- To avoid cross-contamination, use separate pipette tips for all reagents.
RECOMMENDED STORAGE:
Titered material should be stored at -65°C or below.
DO NOT USE IN HUMANS:
These products are intended for research, product development, or quality assurance. These products are NOT intended for use in the manufacture or processing of injectable products subject to licensure under section 351 of the Public Health Service Act or for any other product intended for administration to humans.
Catalog #: 0801892
Corynebacterium diphtheriae Z116, titered (1 mL)
PRODUCT DESCRIPTION: Each frozen aliquot contains 1 mL of a pure, titered culture of Corynebacterium diphtheriae. The identification of this organism was confirmed by 16S sequencing. The purity of the culture was monitored by Gram staining and by additional culturing. The titer was performed on one aliquot after freezing. The freezing medium contains 15% glycerol as a cryoprotectant. Please see the Certificate of Analysis for the specific freezing medium used.
INTENDED USE: Live, titered microorganisms can be used to determine a limit of detection (LOD), in diagnostic assay development or crossreactivity studies. When used as a control for nucleic acid tests, the same protocols as those used to amplify clinical specimens should be employed.
BIOSAFETY: Corynebacterium diphtheriae is a biosafety level 2 microorganism and must be used within Biological Safety Level 2 facility or cabinet. Please consult your institution’s regulations regarding the use of this organism.
PRECAUTIONS:
- Use Universal Precautions, this organism is potentially biohazardous.
- Repetitive freezing and thawing is not recommended (aliquot material if necessary). Titer will be altered by a single freeze-thaw.
- To avoid cross-contamination, use separate pipette tips for all reagents.
RECOMMENDED STORAGE:
Titered material should be stored at -65°C or below.
DO NOT USE IN HUMANS:
These products are intended for research, product development, or quality assurance. These products are NOT intended for use in the manufacture or processing of injectable products subject to licensure under section 351 of the Public Health Service Act or for any other product intended for administration to humans.
Catalog #: 0801882
Staphylococcus simulans Z032, titered (1 mL)
PRODUCT DESCRIPTION: Each frozen aliquot contains 1 mL of a pure, titered culture of Staphylococcus simulans. The identification of this organism was confirmed by 16S sequencing. The purity of the culture was monitored by Gram staining and by additional culturing. The titer was performed on one aliquot after freezing. The freezing medium contains 15% glycerol as a cryoprotectant. Please see the Certificate of Analysis for the specific freezing medium used.
INTENDED USE: Live, titered microorganisms can be used to determine a limit of detection (LOD), in diagnostic assay development or crossreactivity studies. When used as a control for nucleic acid tests, the same protocols as those used to amplify clinical specimens should be employed.
BIOSAFETY: Staphylococcus simulans is a biosafety level 2 microorganism and must be used within Biological Safety Level 2 facility or cabinet. Please consult your institution’s regulations regarding the use of this organism.
PRECAUTIONS:
- Use Universal Precautions, this organism is potentially biohazardous.
- Repetitive freezing and thawing is not recommended (aliquot material if necessary). Titer will be altered by a single freeze-thaw.
- To avoid cross-contamination, use separate pipette tips for all reagents.
RECOMMENDED STORAGE:
Titered material should be stored at -65°C or below.
DO NOT USE IN HUMANS:
These products are intended for research, product development, or quality assurance. These products are NOT intended for use in the manufacture or processing of injectable products subject to licensure under section 351 of the Public Health Service Act or for any other product intended for administration to humans.
Catalog #: 0801728
Staphylococcus lugdunensis Z097, titered (1 mL)
PRODUCT DESCRIPTION: Each frozen aliquot contains 1 mL of a pure, titered culture of Staphylococcus lugdunensis. The identification of this organism was confirmed by 16S sequencing. The purity of the culture was monitored by Gram staining and by additional culturing. The titer was performed on one aliquot after freezing. The freezing medium contains 15% glycerol as a cryoprotectant. Please see the Certificate of Analysis for the specific freezing medium used.
INTENDED USE: Live, titered microorganisms can be used to determine a limit of detection (LOD), in diagnostic assay development or crossreactivity studies. When used as a control for nucleic acid tests, the same protocols as those used to amplify clinical specimens should be employed.
BIOSAFETY: Staphylococcus lugdunensis is a biosafety level 2 microorganism and must be used within Biological Safety Level 2 facility or cabinet. Please consult your institution’s regulations regarding the use of this organism.
PRECAUTIONS:
- Use Universal Precautions, this organism is potentially biohazardous.
- Repetitive freezing and thawing is not recommended (aliquot material if necessary). Titer will be altered by a single freeze-thaw.
- To avoid cross-contamination, use separate pipette tips for all reagents.
RECOMMENDED STORAGE:
Titered material should be stored at -65°C or below.
DO NOT USE IN HUMANS:
These products are intended for research, product development, or quality assurance. These products are NOT intended for use in the manufacture or processing of injectable products subject to licensure under section 351 of the Public Health Service Act or for any other product intended for administration to humans.
Catalog #: 0801555
Candida albicans Z006, DNA (1 μg)
PRODUCT DESCRIPTION: Each aliquot contains 1 μg of DNA extracted from a pure culture of Candida albicans. The identification of this organism was confirmed by rDNA sequencing. The purity of the culture was monitored by additional culturing and Gram staining to detect any contaminating bacteria. The DNA was extracted from the cells following a protocol based on the yeast protocol provided in the Qiagen® Genomic DNA Handbook and using Qiagen® Genomic DNA Buffers with a 500/G genomic tip. DNA concentration and OD260/280 ratios are determined using a NanoDrop ND- 1000®. The extracted DNA also tested positive on an in-house real time PCR assay.
INTENDED USE: Purified Genomic DNA is designed for use as an amplification and/or detection control for nucleic acid testing of Candida albicans. It can also be used to determine a limit of detection (LOD), in diagnostic assay development, cross-reactivity studies or genomic sequencing. When used as a control for nucleic acid tests, the same protocols as those used to amplify extracted clinical specimens should be employed.
PRECAUTIONS:
- Use Universal Precautions when handling Genomic DNA.
- The material may be re-frozen after thawing. Repetitive freezing and thawing is not recommended (aliquot material if necessary).
- To avoid cross-contamination, use separate pipette tips for all reagents.
RECOMMENDED STORAGE:
This control is supplied in TE Buffer and should be frozen at -20°C or below.
DO NOT USE IN HUMANS:
These products are intended for research, product development, quality assurance or manufacturing use. These products are NOT intended for use in the manufacture or processing of injectable products subject to licensure under section 351 of the Public Health Service Act or for any other product intended for administration to humans.
Catalog #: 0801504DNA-1μg
Contact us for additional information
Natural Human Interleukin-2 (IL-2) / T-Cell Growth Factor (TCGF)
PRODUCT CHARACTERISTICS
Each lot of IL-2/TCGF is analyzed for its ability to stimulate proliferation of seven to ten day old PHA-transformed human T- lymphocytes. When used at a final concentration of approximately 10% (v/v), IL-2/TCGF will induce a minimum five- fold increase in cell concentration of such cells when seeded at a density of 2.0 x 105/ ml. IL- 2/TCGF, a glycoprotein with a molecular weight of approximately 15,000 kDa, is produced from pooled human PHA-stimulated T-lymphocytes. IL-2/TCGF is purified by several chromatographic steps to remove PHA and interferon.
CONTENTS
Each 50 ml bottle contains approximately 25,000 BRMP (Biological Response Modifier Program) units of IL-2/TCGF at a concentration of approximately 500 BRMP units/ml. It is supplied as a sterile solution in 25mM HEPES buffered RPMI 1640 culture medium which is free of serum. IL-2/TCGF protein concentration ranges from 8-22 µg/ml.
Download Natural Human Interleukin-2 (IL-2) / T-Cell Growth Factor (TCGF) Datasheet
